Exicure, Inc. (XCUR)
NASDAQ: XCUR · Real-Time Price · USD
5.89
+0.34 (6.13%)
At close: Jun 27, 2025, 4:00 PM
6.24
+0.35 (5.94%)
After-hours: Jun 27, 2025, 7:55 PM EDT
Exicure Employees
Exicure had 7 employees as of December 31, 2024. The number of employees increased by 1 or 16.67% compared to the previous year.
Employees
7
Change (1Y)
1
Growth (1Y)
16.67%
Revenue / Employee
n/a
Profits / Employee
-$837,429
Market Cap
37.21M
Employees Chart
Related Stocks
Company Name | Employees |
---|---|
UnitedHealth Group | 400,000 |
Johnson & Johnson | 138,100 |
Abbott Laboratories | 114,000 |
AstraZeneca | 94,300 |
Novo Nordisk | 77,349 |
Novartis AG | 75,883 |
Merck & Co. | 75,000 |
AbbVie | 55,000 |
XCUR News
- 20 hours ago - Exicure, Inc. Reports First Quarter 2025 Financial Results - Business Wire
- 4 weeks ago - Exicure, Inc. Received Nasdaq Delinquency Notice on Late Filing of its Form 10-Q - Business Wire
- 7 weeks ago - Exicure Completes Patient Enrollment in Phase 2 Study of GPC-100 for Stem Cell Mobilization in Multiple Myeloma Patients Undergoing Autologous Transplant - Business Wire
- 2 months ago - Exicure, Inc. (Nasdaq: XCUR) Nears Completion of Phase 2 Study of GPC-100 in Multiple Myeloma - Business Wire
- 2 months ago - Exicure, Inc. (Nasdaq: XCUR) Announces Their Next Step in Planning for a New Clinical Trial in Acute Myeloid Leukemia (AML) - Business Wire
- 3 months ago - Exicure, Inc. Reports Full Year 2024 Financial Results - Business Wire
- 3 months ago - Exicure, Inc. (Nasdaq: XCUR) Announces Issuance of New Patent in Australia - Business Wire
- 5 months ago - CORRECTING and REPLACING Exicure, Inc. Announces Purchase Agreement with GPCR Therapeutics Inc. - Business Wire